

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 5.30032695 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 5.28269119 |
| 3 | sarcomere organization (GO:0045214) | 5.12190432 |
| 4 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.08925643 |
| 5 | fatty acid transmembrane transport (GO:1902001) | 5.06994228 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 5.04494902 |
| 7 | cardiac myofibril assembly (GO:0055003) | 5.02787251 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.67588996 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.60793534 |
| 10 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.57954019 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.46979037 |
| 12 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.46329694 |
| 13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.41506037 |
| 14 | myofibril assembly (GO:0030239) | 4.38454477 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.29324320 |
| 16 | plasma membrane repair (GO:0001778) | 4.21571558 |
| 17 | cardiac muscle contraction (GO:0060048) | 4.20396389 |
| 18 | detection of calcium ion (GO:0005513) | 4.19688285 |
| 19 | biotin metabolic process (GO:0006768) | 4.08140269 |
| 20 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.06930494 |
| 21 | cell communication by electrical coupling (GO:0010644) | 4.03546318 |
| 22 | carnitine transmembrane transport (GO:1902603) | 4.01197437 |
| 23 | NADH metabolic process (GO:0006734) | 3.96817982 |
| 24 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.94840658 |
| 25 | regulation of fatty acid oxidation (GO:0046320) | 3.94413721 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.93314686 |
| 27 | positive regulation of fatty acid oxidation (GO:0046321) | 3.92178072 |
| 28 | cell communication involved in cardiac conduction (GO:0086065) | 3.83588983 |
| 29 | cGMP-mediated signaling (GO:0019934) | 3.78868723 |
| 30 | muscle filament sliding (GO:0030049) | 3.77136739 |
| 31 | actin-myosin filament sliding (GO:0033275) | 3.77136739 |
| 32 | regulation of actin filament-based movement (GO:1903115) | 3.75256777 |
| 33 | fatty acid beta-oxidation (GO:0006635) | 3.73836647 |
| 34 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.70275957 |
| 35 | regulation of coenzyme metabolic process (GO:0051196) | 3.70068609 |
| 36 | regulation of cofactor metabolic process (GO:0051193) | 3.70068609 |
| 37 | regulation of relaxation of muscle (GO:1901077) | 3.68551243 |
| 38 | amino-acid betaine transport (GO:0015838) | 3.67060987 |
| 39 | carnitine transport (GO:0015879) | 3.67060987 |
| 40 | regulation of membrane repolarization (GO:0060306) | 3.65797958 |
| 41 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.59860516 |
| 42 | regulation of skeletal muscle contraction (GO:0014819) | 3.57044446 |
| 43 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.55470716 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55291816 |
| 45 | cardiac muscle cell development (GO:0055013) | 3.50092029 |
| 46 | low-density lipoprotein particle clearance (GO:0034383) | 3.47906770 |
| 47 | brown fat cell differentiation (GO:0050873) | 3.44215357 |
| 48 | actomyosin structure organization (GO:0031032) | 3.43447702 |
| 49 | cardiac muscle hypertrophy (GO:0003300) | 3.40818546 |
| 50 | regulation of cell communication by electrical coupling (GO:0010649) | 3.37392415 |
| 51 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.35892489 |
| 52 | succinate metabolic process (GO:0006105) | 3.30565750 |
| 53 | lipid particle organization (GO:0034389) | 3.29931184 |
| 54 | cardiac cell development (GO:0055006) | 3.29363103 |
| 55 | regulation of the force of heart contraction (GO:0002026) | 3.29093833 |
| 56 | triglyceride catabolic process (GO:0019433) | 3.28203287 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.27000599 |
| 58 | striated muscle hypertrophy (GO:0014897) | 3.24351624 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.21789166 |
| 60 | actin-mediated cell contraction (GO:0070252) | 3.21453317 |
| 61 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.21419032 |
| 62 | striated muscle contraction (GO:0006941) | 3.20530567 |
| 63 | adult heart development (GO:0007512) | 3.17864227 |
| 64 | valine metabolic process (GO:0006573) | 3.17018871 |
| 65 | heart trabecula formation (GO:0060347) | 3.16887798 |
| 66 | fatty acid homeostasis (GO:0055089) | 3.14858279 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.14018763 |
| 68 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.14018763 |
| 69 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.13973668 |
| 70 | fatty acid catabolic process (GO:0009062) | 3.13961794 |
| 71 | cardiac muscle cell action potential (GO:0086001) | 3.12514436 |
| 72 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.10898783 |
| 73 | fatty acid oxidation (GO:0019395) | 3.10751213 |
| 74 | regulation of striated muscle contraction (GO:0006942) | 3.09824916 |
| 75 | lipid oxidation (GO:0034440) | 3.09401872 |
| 76 | acylglycerol catabolic process (GO:0046464) | 3.07743918 |
| 77 | neutral lipid catabolic process (GO:0046461) | 3.07743918 |
| 78 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.06782752 |
| 79 | branched-chain amino acid catabolic process (GO:0009083) | 3.06330581 |
| 80 | regulation of sulfur metabolic process (GO:0042762) | 3.05957279 |
| 81 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.04811255 |
| 82 | cardiac muscle adaptation (GO:0014887) | 3.04535882 |
| 83 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.04535882 |
| 84 | muscle hypertrophy in response to stress (GO:0003299) | 3.04535882 |
| 85 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.03545467 |
| 86 | response to inactivity (GO:0014854) | 3.00786356 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 2.95379405 |
| 88 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.94090083 |
| 89 | acetyl-CoA metabolic process (GO:0006084) | 2.93388686 |
| 90 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91804196 |
| 91 | cellular response to monoamine stimulus (GO:0071868) | 2.88992886 |
| 92 | cellular response to catecholamine stimulus (GO:0071870) | 2.88992886 |
| 93 | * muscle contraction (GO:0006936) | 2.86726538 |
| 94 | tricarboxylic acid metabolic process (GO:0072350) | 2.86508290 |
| 95 | cellular response to epinephrine stimulus (GO:0071872) | 2.85218752 |
| 96 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.84797917 |
| 97 | branched-chain amino acid metabolic process (GO:0009081) | 2.83233162 |
| 98 | actin filament-based movement (GO:0030048) | 2.82629948 |
| 99 | muscle tissue morphogenesis (GO:0060415) | 2.82494295 |
| 100 | regulation of cardiac muscle contraction (GO:0055117) | 2.82162888 |
| 101 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.81411180 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.81187981 |
| 103 | sodium ion export (GO:0071436) | 2.80621614 |
| 104 | muscle hypertrophy (GO:0014896) | 2.80208414 |
| 105 | quaternary ammonium group transport (GO:0015697) | 2.78504116 |
| 106 | regulation of lipoprotein metabolic process (GO:0050746) | 2.78501782 |
| 107 | adrenergic receptor signaling pathway (GO:0071875) | 2.78127425 |
| 108 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.78032968 |
| 109 | response to epinephrine (GO:0071871) | 2.77385605 |
| 110 | regulation of heart rate (GO:0002027) | 2.74762685 |
| 111 | lysine metabolic process (GO:0006553) | 2.74725264 |
| 112 | lysine catabolic process (GO:0006554) | 2.74725264 |
| 113 | positive regulation of vascular permeability (GO:0043117) | 2.74330349 |
| 114 | white fat cell differentiation (GO:0050872) | 2.73667019 |
| 115 | response to catecholamine (GO:0071869) | 2.73556969 |
| 116 | response to monoamine (GO:0071867) | 2.73556969 |
| 117 | response to dietary excess (GO:0002021) | 2.72352112 |
| 118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72282067 |
| 119 | intracellular lipid transport (GO:0032365) | 2.70342290 |
| 120 | cellular potassium ion homeostasis (GO:0030007) | 2.70031701 |
| 121 | negative regulation of potassium ion transport (GO:0043267) | 2.69141774 |
| 122 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.68134136 |
| 123 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.68134136 |
| 124 | creatine metabolic process (GO:0006600) | 2.66383541 |
| 125 | aspartate family amino acid catabolic process (GO:0009068) | 2.66211792 |
| 126 | relaxation of cardiac muscle (GO:0055119) | 2.66029774 |
| 127 | positive regulation of sodium ion transport (GO:0010765) | 2.65155256 |
| 128 | regulation of heart contraction (GO:0008016) | 2.64940737 |
| 129 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.64673853 |
| 130 | * muscle system process (GO:0003012) | 2.64613237 |
| 131 | positive regulation of potassium ion transport (GO:0043268) | 2.58843339 |
| 132 | regulation of cation channel activity (GO:2001257) | 2.58126898 |
| 133 | cardiac conduction (GO:0061337) | 2.56725105 |
| 134 | positive regulation of cation channel activity (GO:2001259) | 2.55464121 |
| 135 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.54382356 |
| 136 | negative regulation of protein localization to cell surface (GO:2000009) | 2.54181048 |
| 137 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.53255553 |
| 138 | relaxation of muscle (GO:0090075) | 2.53132898 |
| 139 | myelination in peripheral nervous system (GO:0022011) | 2.52573537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.57160427 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.37271065 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.15796169 |
| 4 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.74971228 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.15612758 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03736854 |
| 7 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.02229197 |
| 8 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.02229197 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00973628 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.95984252 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95967462 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91005541 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82691047 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.79072421 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75284573 |
| 16 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74497613 |
| 17 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74497613 |
| 18 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73914223 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70975682 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69703464 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65657624 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65440730 |
| 23 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62719183 |
| 24 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52299461 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50024518 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48366606 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.46498174 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44557562 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43758161 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43289963 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41571995 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39755303 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38066816 |
| 34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37692254 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36770866 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35152963 |
| 37 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.34698425 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34631147 |
| 39 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.34279557 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33636072 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33556381 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32884969 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29926800 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25495710 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25241664 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24750175 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24654323 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23920808 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21704392 |
| 50 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21324438 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20157897 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19782440 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19601777 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18225872 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17831588 |
| 56 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16278641 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16060439 |
| 58 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15738058 |
| 59 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14724598 |
| 60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14289829 |
| 61 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14014383 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13493254 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12977278 |
| 64 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11100437 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10557512 |
| 66 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10171316 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09793473 |
| 68 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09189334 |
| 69 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06278996 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05717066 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04688976 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04475133 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04287099 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04262446 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04202064 |
| 76 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03590733 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03224649 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03189666 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03040727 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03002223 |
| 81 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02647041 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01743443 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01689627 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01318814 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00250304 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98515274 |
| 87 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.97696675 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97642445 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96208197 |
| 90 | * AR_19668381_ChIP-Seq_PC3_Human | 0.96201423 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95904363 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95268715 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95166398 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95056738 |
| 95 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94645478 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93774562 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93587685 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93579556 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93558942 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93558942 |
| 101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93493049 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92863057 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92012451 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90992251 |
| 105 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90422611 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90186683 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89751871 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89043533 |
| 109 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88710963 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88613067 |
| 111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88378333 |
| 112 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88357588 |
| 113 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86611942 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86435947 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84710801 |
| 116 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84631974 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83962594 |
| 118 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83728925 |
| 119 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82799975 |
| 120 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82010188 |
| 121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81159940 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.80352110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.27732781 |
| 2 | MP0003646_muscle_fatigue | 4.51996006 |
| 3 | MP0000751_myopathy | 4.24207985 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.99913020 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.86374489 |
| 6 | MP0004130_abnormal_muscle_cell | 3.75275038 |
| 7 | * MP0005670_abnormal_white_adipose | 3.24417326 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.98837639 |
| 9 | MP0000749_muscle_degeneration | 2.90148484 |
| 10 | MP0005330_cardiomyopathy | 2.87392345 |
| 11 | * MP0005666_abnormal_adipose_tissue | 2.59988168 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.48272113 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.46161786 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.45547998 |
| 15 | MP0006138_congestive_heart_failure | 2.40077924 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.37761139 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.22855532 |
| 18 | MP0000750_abnormal_muscle_regeneration | 2.20282462 |
| 19 | MP0005385_cardiovascular_system_phenoty | 2.14800482 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.14800482 |
| 21 | MP0003137_abnormal_impulse_conducting | 2.14749721 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 2.11120660 |
| 23 | * MP0005375_adipose_tissue_phenotype | 2.02386892 |
| 24 | MP0004484_altered_response_of | 1.97615790 |
| 25 | MP0010630_abnormal_cardiac_muscle | 1.82139230 |
| 26 | MP0002269_muscular_atrophy | 1.77416267 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.76370493 |
| 28 | MP0002106_abnormal_muscle_physiology | 1.76084793 |
| 29 | MP0000003_abnormal_adipose_tissue | 1.75070612 |
| 30 | MP0002971_abnormal_brown_adipose | 1.69354246 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.66758648 |
| 32 | MP0003828_pulmonary_edema | 1.66302234 |
| 33 | MP0004085_abnormal_heartbeat | 1.65326591 |
| 34 | MP0000759_abnormal_skeletal_muscle | 1.61610955 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.55364241 |
| 36 | MP0000747_muscle_weakness | 1.54262563 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.50775850 |
| 38 | MP0005369_muscle_phenotype | 1.50716251 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.43856501 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.40255894 |
| 41 | MP0004233_abnormal_muscle_weight | 1.39899495 |
| 42 | MP0004272_abnormal_basement_membrane | 1.34941763 |
| 43 | MP0001984_abnormal_olfaction | 1.33310955 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.32260734 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.31532043 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.30003244 |
| 47 | MP0001486_abnormal_startle_reflex | 1.28457149 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.23699345 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.20209966 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19345073 |
| 51 | MP0002272_abnormal_nervous_system | 1.18201236 |
| 52 | MP0002064_seizures | 1.17514644 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.17124112 |
| 54 | MP0003279_aneurysm | 1.16232775 |
| 55 | MP0003879_abnormal_hair_cell | 1.16224563 |
| 56 | MP0005275_abnormal_skin_tensile | 1.15835757 |
| 57 | MP0005334_abnormal_fat_pad | 1.15074205 |
| 58 | MP0002063_abnormal_learning/memory/cond | 1.11963467 |
| 59 | MP0009745_abnormal_behavioral_response | 1.11140230 |
| 60 | MP0004859_abnormal_synaptic_plasticity | 1.10311729 |
| 61 | * MP0009115_abnormal_fat_cell | 1.09704417 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.09201669 |
| 63 | MP0005535_abnormal_body_temperature | 1.08588279 |
| 64 | MP0002108_abnormal_muscle_morphology | 1.03542398 |
| 65 | MP0003045_fibrosis | 1.01796526 |
| 66 | MP0003880_abnormal_central_pattern | 0.96585181 |
| 67 | MP0004858_abnormal_nervous_system | 0.96320461 |
| 68 | * MP0002118_abnormal_lipid_homeostasis | 0.96149698 |
| 69 | MP0000230_abnormal_systemic_arterial | 0.95971971 |
| 70 | MP0003690_abnormal_glial_cell | 0.94112784 |
| 71 | MP0005165_increased_susceptibility_to | 0.94055403 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 0.93679946 |
| 73 | MP0006276_abnormal_autonomic_nervous | 0.93620508 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.92290670 |
| 75 | MP0002735_abnormal_chemical_nociception | 0.91698960 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.89651811 |
| 77 | MP0001502_abnormal_circadian_rhythm | 0.88196627 |
| 78 | MP0002970_abnormal_white_adipose | 0.87387128 |
| 79 | MP0004510_myositis | 0.86660454 |
| 80 | MP0000343_altered_response_to | 0.84545892 |
| 81 | MP0001958_emphysema | 0.83442313 |
| 82 | MP0002572_abnormal_emotion/affect_behav | 0.83166927 |
| 83 | MP0003868_abnormal_feces_composition | 0.82309084 |
| 84 | MP0005595_abnormal_vascular_smooth | 0.80324018 |
| 85 | MP0005448_abnormal_energy_balance | 0.80292387 |
| 86 | * MP0002078_abnormal_glucose_homeostasis | 0.79154272 |
| 87 | MP0005623_abnormal_meninges_morphology | 0.78578959 |
| 88 | MP0004147_increased_porphyrin_level | 0.77914121 |
| 89 | MP0000266_abnormal_heart_morphology | 0.76543928 |
| 90 | MP0003329_amyloid_beta_deposits | 0.76043168 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.75395233 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.74917836 |
| 93 | MP0001661_extended_life_span | 0.74308417 |
| 94 | MP0002822_catalepsy | 0.72665738 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.72423286 |
| 96 | MP0004924_abnormal_behavior | 0.72423286 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.71287564 |
| 98 | MP0004885_abnormal_endolymph | 0.70469055 |
| 99 | MP0005409_darkened_coat_color | 0.70418016 |
| 100 | MP0001970_abnormal_pain_threshold | 0.70235573 |
| 101 | MP0001501_abnormal_sleep_pattern | 0.69992668 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.69840258 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.69728495 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.68699524 |
| 105 | MP0000778_abnormal_nervous_system | 0.67447730 |
| 106 | MP0000920_abnormal_myelination | 0.66775987 |
| 107 | MP0005452_abnormal_adipose_tissue | 0.66346171 |
| 108 | MP0008569_lethality_at_weaning | 0.62526011 |
| 109 | MP0002128_abnormal_blood_circulation | 0.60980229 |
| 110 | MP0005266_abnormal_metabolism | 0.59269864 |
| 111 | MP0003635_abnormal_synaptic_transmissio | 0.57921139 |
| 112 | MP0005365_abnormal_bile_salt | 0.57665849 |
| 113 | MP0003948_abnormal_gas_homeostasis | 0.57417129 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.56735081 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.52790088 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.52703315 |
| 117 | MP0004270_analgesia | 0.52515874 |
| 118 | MP0003959_abnormal_lean_body | 0.52139030 |
| 119 | MP0009046_muscle_twitch | 0.51943734 |
| 120 | MP0002638_abnormal_pupillary_reflex | 0.50874342 |
| 121 | MP0003633_abnormal_nervous_system | 0.49610794 |
| 122 | MP0005332_abnormal_amino_acid | 0.48417334 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.46246520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.26379793 |
| 2 | Muscle fiber splitting (HP:0003555) | 5.12226617 |
| 3 | Ventricular tachycardia (HP:0004756) | 5.10611173 |
| 4 | Atrial fibrillation (HP:0005110) | 5.07289797 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.84875872 |
| 6 | Primary atrial arrhythmia (HP:0001692) | 4.74826992 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.70115704 |
| 8 | Myoglobinuria (HP:0002913) | 4.68903853 |
| 9 | Lipoatrophy (HP:0100578) | 4.61671823 |
| 10 | Supraventricular tachycardia (HP:0004755) | 4.51835236 |
| 11 | Supraventricular arrhythmia (HP:0005115) | 4.47303150 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 4.44359630 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.41952828 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.31924357 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.23636076 |
| 16 | Muscle fiber inclusion bodies (HP:0100299) | 4.17642714 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.14705086 |
| 18 | Bundle branch block (HP:0011710) | 4.10424146 |
| 19 | Nemaline bodies (HP:0003798) | 4.06116138 |
| 20 | Increased connective tissue (HP:0009025) | 4.01477728 |
| 21 | Syncope (HP:0001279) | 4.01294999 |
| 22 | Difficulty running (HP:0009046) | 3.95368352 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.90549784 |
| 24 | Prolonged QT interval (HP:0001657) | 3.80913808 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 3.60472572 |
| 26 | Palpitations (HP:0001962) | 3.57592933 |
| 27 | Atrioventricular block (HP:0001678) | 3.57190291 |
| 28 | Heart block (HP:0012722) | 3.44007811 |
| 29 | Ventricular arrhythmia (HP:0004308) | 3.40647542 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.26593756 |
| 31 | Subaortic stenosis (HP:0001682) | 3.26593756 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.25042387 |
| 33 | EMG: neuropathic changes (HP:0003445) | 3.24919004 |
| 34 | Abnormal atrioventricular conduction (HP:0005150) | 3.23723064 |
| 35 | Rhabdomyolysis (HP:0003201) | 3.21507590 |
| 36 | Oligomenorrhea (HP:0000876) | 3.20117169 |
| 37 | Myotonia (HP:0002486) | 3.14262055 |
| 38 | Ketoacidosis (HP:0001993) | 3.12426540 |
| 39 | Hyperglycinuria (HP:0003108) | 3.11796039 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 3.06048608 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 2.99294287 |
| 42 | Ventricular fibrillation (HP:0001663) | 2.94290712 |
| 43 | Rimmed vacuoles (HP:0003805) | 2.92714126 |
| 44 | Frequent falls (HP:0002359) | 2.91414941 |
| 45 | Hypoglycemic coma (HP:0001325) | 2.88849177 |
| 46 | Abnormal EKG (HP:0003115) | 2.86876392 |
| 47 | Difficulty climbing stairs (HP:0003551) | 2.79509650 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72447447 |
| 49 | Aortic aneurysm (HP:0004942) | 2.68283949 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67171545 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.63615924 |
| 52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60514364 |
| 53 | Acanthosis nigricans (HP:0000956) | 2.58477032 |
| 54 | Myokymia (HP:0002411) | 2.56531977 |
| 55 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.52460446 |
| 56 | Broad metatarsal (HP:0001783) | 2.52184933 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.51781555 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.51781555 |
| 59 | Left ventricular hypertrophy (HP:0001712) | 2.51430602 |
| 60 | Action tremor (HP:0002345) | 2.50844750 |
| 61 | Ketosis (HP:0001946) | 2.49673306 |
| 62 | Steppage gait (HP:0003376) | 2.44623373 |
| 63 | Focal motor seizures (HP:0011153) | 2.39967610 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.33759638 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33759638 |
| 66 | Hypoalphalipoproteinemia (HP:0003233) | 2.30057092 |
| 67 | Pheochromocytoma (HP:0002666) | 2.28746483 |
| 68 | Dysmetric saccades (HP:0000641) | 2.26733631 |
| 69 | Muscle stiffness (HP:0003552) | 2.24899089 |
| 70 | Facial diplegia (HP:0001349) | 2.18371188 |
| 71 | Testicular atrophy (HP:0000029) | 2.17041011 |
| 72 | Complement deficiency (HP:0004431) | 2.14101845 |
| 73 | Muscular dystrophy (HP:0003560) | 2.12537685 |
| 74 | Bradycardia (HP:0001662) | 2.10952450 |
| 75 | Hypertriglyceridemia (HP:0002155) | 2.09137799 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.06713510 |
| 77 | Spinal rigidity (HP:0003306) | 2.04574482 |
| 78 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04019425 |
| 79 | Abnormality of alanine metabolism (HP:0010916) | 2.04019425 |
| 80 | Hyperalaninemia (HP:0003348) | 2.04019425 |
| 81 | Hyperammonemia (HP:0001987) | 2.03392331 |
| 82 | Hepatic necrosis (HP:0002605) | 2.01668853 |
| 83 | Proximal amyotrophy (HP:0007126) | 2.00663057 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00593827 |
| 85 | Lower limb amyotrophy (HP:0007210) | 1.99567231 |
| 86 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99382871 |
| 87 | Neck muscle weakness (HP:0000467) | 1.98882863 |
| 88 | Scapular winging (HP:0003691) | 1.98673878 |
| 89 | Focal seizures (HP:0007359) | 1.94289488 |
| 90 | Abnormal eating behavior (HP:0100738) | 1.94038133 |
| 91 | Central scotoma (HP:0000603) | 1.93806973 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 1.92339019 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.92108007 |
| 94 | Obstructive sleep apnea (HP:0002870) | 1.90820339 |
| 95 | Bulbar palsy (HP:0001283) | 1.90133295 |
| 96 | Hyperglycemia (HP:0003074) | 1.89061299 |
| 97 | Round ear (HP:0100830) | 1.87818910 |
| 98 | Hypoplastic ischia (HP:0003175) | 1.87792309 |
| 99 | Distal arthrogryposis (HP:0005684) | 1.87016930 |
| 100 | Palmoplantar keratoderma (HP:0000982) | 1.86682339 |
| 101 | Bone cyst (HP:0012062) | 1.85023349 |
| 102 | Limb-girdle muscle atrophy (HP:0003797) | 1.84365269 |
| 103 | Hamartoma of the eye (HP:0010568) | 1.83645930 |
| 104 | Gowers sign (HP:0003391) | 1.79668207 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79189970 |
| 106 | Areflexia of lower limbs (HP:0002522) | 1.79137632 |
| 107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78100755 |
| 108 | Generalized muscle weakness (HP:0003324) | 1.77987169 |
| 109 | Foot dorsiflexor weakness (HP:0009027) | 1.77784456 |
| 110 | Neoplasm of the heart (HP:0100544) | 1.76766157 |
| 111 | Toxemia of pregnancy (HP:0100603) | 1.76140820 |
| 112 | Abnormality of the foot musculature (HP:0001436) | 1.74790799 |
| 113 | Skin nodule (HP:0200036) | 1.74640668 |
| 114 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.74291323 |
| 115 | Large hands (HP:0001176) | 1.73591620 |
| 116 | Abnormality of the ischium (HP:0003174) | 1.73416736 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.73323641 |
| 118 | Athetosis (HP:0002305) | 1.72978001 |
| 119 | Congestive heart failure (HP:0001635) | 1.72707164 |
| 120 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.72470402 |
| 121 | Myopathic facies (HP:0002058) | 1.72307849 |
| 122 | Conjunctival hamartoma (HP:0100780) | 1.70431853 |
| 123 | Febrile seizures (HP:0002373) | 1.68970620 |
| 124 | Cerebral aneurysm (HP:0004944) | 1.67361056 |
| 125 | Sudden cardiac death (HP:0001645) | 1.67328181 |
| 126 | Cerebral edema (HP:0002181) | 1.66454504 |
| 127 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65588976 |
| 128 | Rapidly progressive (HP:0003678) | 1.65158691 |
| 129 | Lymphangioma (HP:0100764) | 1.63273579 |
| 130 | Slow progression (HP:0003677) | 1.62697532 |
| 131 | Limited hip movement (HP:0008800) | 1.62116752 |
| 132 | Hemiplegia (HP:0002301) | 1.61342761 |
| 133 | Aneurysm (HP:0002617) | 1.60333216 |
| 134 | Hyperlipoproteinemia (HP:0010980) | 1.59740315 |
| 135 | Lower limb muscle weakness (HP:0007340) | 1.58967297 |
| 136 | Ragged-red muscle fibers (HP:0003200) | 1.57589674 |
| 137 | Infantile muscular hypotonia (HP:0008947) | 1.57215719 |
| 138 | Hip contracture (HP:0003273) | 1.55506714 |
| 139 | Generalized tonic-clonic seizures (HP:0002069) | 1.54614553 |
| 140 | Hypoplasia of the iris (HP:0007676) | 1.52916748 |
| 141 | Ankle clonus (HP:0011448) | 1.52869475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.23312130 |
| 2 | TTN | 3.66954350 |
| 3 | PHKG2 | 3.47271641 |
| 4 | PHKG1 | 3.47271641 |
| 5 | TRIB3 | 3.11425808 |
| 6 | PDK3 | 3.02163253 |
| 7 | PDK4 | 3.02163253 |
| 8 | TIE1 | 2.81736031 |
| 9 | CAMK1D | 2.81627158 |
| 10 | OBSCN | 2.72844531 |
| 11 | BCKDK | 2.68594966 |
| 12 | MYLK | 2.66869215 |
| 13 | DMPK | 2.23528349 |
| 14 | CAMK1G | 2.23155017 |
| 15 | SIK1 | 2.01835193 |
| 16 | PINK1 | 1.82136191 |
| 17 | PIK3CA | 1.75792088 |
| 18 | MUSK | 1.75220191 |
| 19 | PDK2 | 1.74584050 |
| 20 | RIPK1 | 1.66622710 |
| 21 | PKN2 | 1.61594452 |
| 22 | PRKD3 | 1.59500023 |
| 23 | INSRR | 1.52633998 |
| 24 | CASK | 1.40390267 |
| 25 | PAK3 | 1.35154181 |
| 26 | NEK1 | 1.31850350 |
| 27 | PRKAA2 | 1.27351012 |
| 28 | LATS2 | 1.20576310 |
| 29 | UHMK1 | 1.16466798 |
| 30 | CAMK2B | 1.14843403 |
| 31 | PDGFRA | 1.14167788 |
| 32 | PRKAA1 | 1.13192409 |
| 33 | MAP3K4 | 1.05360373 |
| 34 | LATS1 | 1.05189254 |
| 35 | STK38 | 1.03460807 |
| 36 | PRKD1 | 1.02621659 |
| 37 | ROCK1 | 1.00626005 |
| 38 | MAPK4 | 1.00452387 |
| 39 | SGK3 | 0.97658439 |
| 40 | SGK2 | 0.96888154 |
| 41 | PAK6 | 0.95912283 |
| 42 | TGFBR2 | 0.95625845 |
| 43 | CAMK2D | 0.95511842 |
| 44 | EEF2K | 0.93574008 |
| 45 | EPHA4 | 0.92646582 |
| 46 | MAPK12 | 0.89980548 |
| 47 | FER | 0.85846855 |
| 48 | NTRK1 | 0.84862624 |
| 49 | NTRK3 | 0.83354985 |
| 50 | MAPKAPK3 | 0.83148978 |
| 51 | STK38L | 0.82457516 |
| 52 | NEK9 | 0.80658367 |
| 53 | SGK494 | 0.80569379 |
| 54 | SGK223 | 0.80569379 |
| 55 | CAMK1 | 0.80164120 |
| 56 | PTK2B | 0.79233967 |
| 57 | NTRK2 | 0.77891611 |
| 58 | CDC42BPA | 0.77534919 |
| 59 | MAP3K7 | 0.76672047 |
| 60 | PRKCH | 0.75772270 |
| 61 | MAP2K1 | 0.74053288 |
| 62 | NLK | 0.73864341 |
| 63 | MAPK7 | 0.73181242 |
| 64 | TNIK | 0.69075661 |
| 65 | MAP2K4 | 0.67807243 |
| 66 | PIK3CG | 0.65527671 |
| 67 | GRK7 | 0.65164557 |
| 68 | PRKCE | 0.64281132 |
| 69 | RET | 0.62493197 |
| 70 | MAPK10 | 0.61902662 |
| 71 | ILK | 0.60537705 |
| 72 | CAMK2A | 0.60458457 |
| 73 | PDPK1 | 0.60321987 |
| 74 | GRK5 | 0.60294978 |
| 75 | MAP3K6 | 0.59165108 |
| 76 | KSR2 | 0.59048518 |
| 77 | PRKACG | 0.58562496 |
| 78 | MST1R | 0.57855574 |
| 79 | CAMK4 | 0.57618477 |
| 80 | EPHB2 | 0.57090287 |
| 81 | FGFR3 | 0.54001546 |
| 82 | MARK2 | 0.53717286 |
| 83 | MARK1 | 0.53454299 |
| 84 | ROCK2 | 0.52232120 |
| 85 | EPHB1 | 0.51815568 |
| 86 | DDR2 | 0.50960924 |
| 87 | LIMK1 | 0.50914716 |
| 88 | STK24 | 0.50551393 |
| 89 | PAK2 | 0.49420648 |
| 90 | FGFR2 | 0.47991284 |
| 91 | TYRO3 | 0.47440613 |
| 92 | CAMKK2 | 0.46214596 |
| 93 | MINK1 | 0.45816283 |
| 94 | MAP3K5 | 0.45737983 |
| 95 | SGK1 | 0.45040354 |
| 96 | PDGFRB | 0.44580340 |
| 97 | MAP3K13 | 0.44534080 |
| 98 | ICK | 0.44520417 |
| 99 | AKT3 | 0.44192407 |
| 100 | ZAK | 0.43058469 |
| 101 | PRKACB | 0.42877782 |
| 102 | DYRK1A | 0.41699678 |
| 103 | PRKACA | 0.41398385 |
| 104 | CAMK2G | 0.40063005 |
| 105 | PDK1 | 0.39234028 |
| 106 | DAPK2 | 0.39092972 |
| 107 | JAK1 | 0.38014284 |
| 108 | PKN1 | 0.37783069 |
| 109 | TRPM7 | 0.37133617 |
| 110 | EPHA3 | 0.37023247 |
| 111 | CDK5 | 0.36821822 |
| 112 | MTOR | 0.36468305 |
| 113 | WNK1 | 0.35807530 |
| 114 | CAMKK1 | 0.34517976 |
| 115 | KDR | 0.33410429 |
| 116 | AKT2 | 0.33352998 |
| 117 | * RPS6KA3 | 0.32161712 |
| 118 | PRKG1 | 0.29960273 |
| 119 | STK11 | 0.29695860 |
| 120 | MAPK13 | 0.28945977 |
| 121 | DAPK3 | 0.27728679 |
| 122 | WNK4 | 0.27444275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.50552800 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.55162932 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.39083449 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83776739 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.78448642 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63288486 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.60340367 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.48646741 |
| 9 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.38055182 |
| 10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.26521203 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.25134505 |
| 12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.03009228 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 1.91727480 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89476274 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88293863 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.72141729 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71937014 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56718328 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56649050 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49434898 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45070185 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37518191 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.37134646 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.34989392 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32478972 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18534860 |
| 27 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.18363255 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18140796 |
| 29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15464741 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09503161 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.07788802 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05153549 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04078489 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.01684822 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01045894 |
| 36 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00844348 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00061591 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96793703 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96063985 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92929343 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92239509 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89702841 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.89544206 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89137634 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87047699 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84141483 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83606491 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82689476 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81685515 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81262927 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80286980 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80148622 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 0.77227391 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75545614 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75240063 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75009766 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74210040 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73276461 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73141927 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 0.72628486 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71974222 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70295478 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.69606655 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69087946 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68371702 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67926264 |
| 67 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.67611549 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.67182714 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.67087813 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.66600600 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65590263 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64534030 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64018757 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63133067 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62818621 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.61675552 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61408330 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60276183 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57401131 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.57346507 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57329019 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57250055 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55468390 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55458526 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54959510 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54287636 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53194840 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52967275 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52129483 |
| 90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51165887 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.50102127 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48979866 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46530199 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46296330 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45002636 |
| 96 | Axon guidance_Homo sapiens_hsa04360 | 0.44405556 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43892493 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43773666 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.43382711 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.41018873 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40869554 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.40233157 |
| 103 | * Adherens junction_Homo sapiens_hsa04520 | 0.39523259 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37750873 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36864848 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35655986 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35529872 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.34657234 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33824272 |
| 110 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33336512 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.31672879 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31670461 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30361440 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.30254874 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29174873 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27790809 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27586563 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27536940 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26800220 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23897883 |

